Sculptor Capital LP Humanigen, Inc Put Options Transaction History

Sculptor Capital LP

  • $2.76 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.76 - $3.33 $68,288 - $129,204
-38,800 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$3.66 - $8.22 $31,842 - $71,514
-8,700 Reduced 18.32%
38,800 $144,000
Q3 2021

Nov 12, 2021
BUY
$5.93 - $17.83 $210,515 - $632,964
35,500 Added 295.83%
47,500 $282,000
Q1 2021

May 14, 2021
BUY
$12.91 - $23.83 $154,920 - $285,960
12,000 New
12,000 $229,000

Others Institutions Holding HGEN

# of Institutions
4
Shares Held
558K
Call Options Held
0
Put Options Held
0
View Full List

About HUMANIGEN, INC

HGEN Quotes by TradingView
  • Ticker HGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,661,000
  • Description
  • Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...
More about HGEN
Track This Portfolio

Track Sculptor Capital LP Portfolio

Follow Sculptor Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sculptor Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email